| Date | Name | Shares | Transaction | Value |
|
Mar 24, 2026
| Ann D. Janssen EVP & Chief Financial Officer |
N/A
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
|
Mar 24, 2026
| Ann D. Janssen EVP & Chief Financial Officer |
109,611
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $37.44 per share |
4,103,835.84
|
|
Mar 24, 2026
| Ann D. Janssen EVP & Chief Financial Officer |
107,107
| Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 Non-derivative transaction at $140.06 per share |
15,001,406.42
|
|
Mar 24, 2026
| Ann D. Janssen EVP & Chief Financial Officer |
104,407
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $140.06 per share |
14,623,244.42
|
|
Mar 24, 2026
| Ann D. Janssen EVP & Chief Financial Officer |
100,246
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $140.04 per share |
14,038,449.84
|
|
Mar 17, 2026
| Ann D. Janssen EVP & Chief Financial Officer |
N/A
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
|
Mar 17, 2026
| Ann D. Janssen EVP & Chief Financial Officer |
5,000
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
|
Mar 17, 2026
| Ann D. Janssen EVP & Chief Financial Officer |
100,246
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $133.76 per share |
13,408,904.96
|
|
Mar 17, 2026
| Ann D. Janssen EVP & Chief Financial Officer |
101,668
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $133.76 per share |
13,599,111.68
|
|
Mar 17, 2026
| Ann D. Janssen EVP & Chief Financial Officer |
102,439
| Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 Non-derivative transaction at $133.76 per share |
13,702,240.64
|
|
Mar 4, 2026
| Jeffrey R. Leitzell EVP & COO |
91,819
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $124.08 per share |
11,392,901.52
|
|
Mar 4, 2026
| Ezra Y. Yacob Chairman & CEO; Director |
278,225
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $124.08 per share |
34,522,158.00
|
|
Mar 4, 2026
| Michael P. Donaldson EVP & Chief Legal Officer |
107,358
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $124.08 per share |
13,320,980.64
|
|
Feb 4, 2026
| Christopher C. Gaut Director |
21,242
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $112.13 per share |
2,381,865.46
|
|
Feb 4, 2026
| Janet F. Clark Director |
47,371
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $112.13 per share |
5,311,710.23
|
|
Feb 4, 2026
| Robert P. Daniels Director |
32,700
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $112.13 per share |
3,666,651.00
|
|
Feb 4, 2026
| Lynn A. Dugle Director |
6,027
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $112.13 per share |
675,807.51
|
|
Feb 4, 2026
| Charles R. Crisp Director |
63,210
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $112.13 per share |
7,087,737.30
|
|
Dec 18, 2025
| John D. Chandler Director |
826
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Oct 28, 2025
| Jeffrey R. Leitzell EVP & COO |
56,973
| Open market or private purchase of non-derivative security Non-derivative transaction at $107.97 per share |
6,151,374.81
|